OIS@ASCRS
InnFocus’ MicroShunt is the only micro-invasive glaucoma surgery (MIGS) device undergoing a randomized clinical trial that uses trabeculectomy as the comparator. “We want to get…
Read MoreClarVista Medical is a clinical-stage ophthalmic company that is introducing the HARMONI Modular IOL system to help surgeons navigate “the increasingly demanding environment of cataract…
Read MoreElizabeth Yeu, MD, led the “Spotlight on the Premium Channel” discussion at OIS@ASCRS 2016. In her session, representatives from AcuFocus, Bausch + Lomb, Abbott Medical…
Read MoreVance Thompson, MD is an internationally recognized specialist in Laser Vision Correction and Advanced Cataract Surgery. As a leading international researcher he has played a…
Read MoreIvantis was founded in 2007 by two coronary stent inventors to develop “the only minimally invasive microstent for glaucoma that dilates and scaffolds Schlemm’s canal.”…
Read MoreResults from a Phase I/Phase II study of EV06 ophthalmic solution for the treatment of presbyopia show “it works to restore bilateral near vision. It…
Read MoreThe Raindrop Near Vision Inlay for the treatment of presbyopia boasts a 2-mm diameter, 80% water composition, the same refractive index as the natural cornea,…
Read MoreBarry Cheskin, CEO, president and co-founder of PowerVision, provides details on his company’s new partnership with Alcon. Video Highlights: 00:30 – Details on Alcon deal…
Read MoreAllergan purchased AqueSys (developer of the Xen Gel Stent) in a $20 million deal earlier this year. “Just a few years ago, the energy and…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.